|
Barry A. Labinger joined HGS in August 2005 as Executive Vice President and Chief Commercial Officer. Mr. Labinger has more than 15 years of experience in the biopharmaceutical industry including leadership of launches and marketing of a number of successful products in a variety of therapeutic areas. Mr. Labinger was most recently with 3M Pharmaceuticals where he served as Division Vice President. 3M Pharmaceuticals is a global division of 3M Company with marketed products in dermatology women’s health and cardiac therapy along with a pipeline of immune response modifiers for the treatment of viral infections and cancers. From 2000 to 2002 Mr. Labinger was Senior Vice President and General Manager Commercial Operations at Immunex Corporation where he led both the Enbrel and Specialty Therapeutics franchise teams and had direct responsibility for the sales and marketing organizations. Mr. Labinger also served as Senior Director of Diabetes Marketing and Director of Glucophage Marketing at Bristol-Myers Squibb. Mr. Labinger began his pharmaceutical career at Abbott Laboratories where he was involved in the commercialization of products for gastrointestinal and infectious diseases. Mr. Labinger earned a Master of Business Administration from the J.L. Kellogg Graduate School of Management at Northwestern University and a Bachelor of Arts in economics from Northwestern University. | 